Background: Whether local anesthetics exert anti-inflammatory effects in fetal and newborn systemic neutrophils is unclear. The aim of the present study was to assess the effects of bupivacaine and lidocaine on the respiratory burst of cord blood neutrophils in vitro compared with adult cells. Methods: Whole cord blood (n = 12) and control adult blood samples (n = 7) were incubated with bupivacaine (0.0005, 0.005, 0.05, 1 mmol/l) and lidocaine (0.002, 0.02, 0.2, 4 mmol/l) for 1 and 4 h. The production of reactive oxygen species (ROS) by unstimulated neutrophils and the phorbol myristate acetate-induced oxidative burst were assessed by flow cytometry. A subset of neutrophils showing high fluorescence intensity (rho+) was analyzed separately. results: After 1 h incubation, local anesthetics decreased the respiratory burst in whole cord blood and adult neutrophils in a similar manner. At the clinically relevant concentration of 0.0005 mmol/l, bupivacaine was active, but its effect in cord blood cells could not be detected after 4 h. The cord blood rho+ cell subset was unresponsive to the inhibitory action of bupivacaine. In rho+ neutrophils, basal ROS production was stimulated by lidocaine at the lowest concentration tested. conclusion: Bupivacaine and lidocaine can decrease the respiratory burst in neutrophils of term newborns. t he question of the effects of local anesthetics (LAs) on fetal neutrophils arises in the clinical context of the broad application of neuraxial blockade in obstetrics. Epidural technics are the gold standard for labor intrapartum analgesia and are administered to parturients on request. By applying higher doses of LAs through the existing epidural catheter, surgical anesthesia for cesarean delivery may be easily obtained. The fetal and neonatal implications of epidural techniques are mostly considered to be indirect and dependent on modulation of maternal physiology, and are associated with a higher risk of neonatal pyrexia and sepsis evaluation, but not neonatal infection (1-3). The reasons for these findings are not sufficiently clear. However, direct fetal and neonatal effects of LAs as a result of placental drug transfer should not be entirely excluded. LAs administered epidurally enter the maternal systemic circulation and, after crossing the placental barrier, can reach the fetal circulation, with levels approximately one-third to half those seen in the maternal circulation. Furthermore, because of ion trapping and slower elimination, LAs may persist for longer in fetal and neonatal than maternal blood (4). LAs in the fetal systemic circulation have been reported to abolish an offspring's cardiovascular adaptive reaction to asphyxia (5) and have been suggested to affect blood cells. Specifically, bupivacaine has been shown to modify plasma membrane properties of fetal erythrocytes (6). In other studies, lidocaine, a prototypical amino-amide agent administered epidurally for cesarean sections, was suggested to be responsible for the inhibition of natural killer cells and neutrophil a...